Wegovy Pill Hits 3 Million Scripts: Is $149 a Good Deal?
Author
glp winnerDate Published
- Twitter
- Facebook
- LinkedIn
- Instagram
- Copy Link
Yes. For a lot of people paying cash and looking for an FDA-approved oral option, the new Wegovy Pill is now the lowest-cost way to start a GLP-1 medicine. It is $149 a month for the starting doses, though the full 25 mg maintenance dose costs $299 a month self-pay (NovoCare).
On June 7, 2026, Novo Nordisk announced that Wegovy Pills had passed 3 million prescriptions in just over five months, with roughly one filled every five seconds (Novo Nordisk). If you are trying to decide between the tablet, the pen, or a compounded option, this guide walks through the price, the results, and how to tell what fits you. Before you talk with a prescriber, you can also compare providers and pricing for the Wegovy Pill in one place.
Who This Helps
This post is for you if any of these sound like your situation:
- A grandparent who wants help with weight but would rather not deal with a weekly injection.
- A busy parent paying cash who wants to know the monthly price before committing to anything.
- Someone lining up the tablet, the pen, and compounded GLP-1 products to see how they compare.
- A Medicare Part D member who has heard about a new $50 copay program and wants to know how it works.
What Does 3 Million Prescriptions in 5 Months Actually Mean?
The Wegovy Pill reached 3 million prescriptions in just over five months, roughly one filled every five seconds (Novo Nordisk). And 82% of the new pill prescriptions went to people who had never used a GLP-1 medicine before. So the tablet is reaching first-timers and folks who wanted access to GLP-1s but stayed away during the injection-only years.
The timing is what makes those numbers stand out. The FDA approved Wegovy Pills on December 22, 2025, so all of this happened during the pill's first half-year on pharmacy shelves (FDA). Novo Nordisk shared the milestone on June 7, 2026, along with new study data.
For years, the needle kept a lot of people from ever starting. A daily tablet takes that worry off the table, and the 82% figure suggests it is doing exactly that. If you want the fuller picture on how tablets could change who gets treated, our earlier piece on the oral GLP-1 race lays it out.
How Does the Wegovy Pill Work, and How Do You Take It?
The Wegovy Pill is oral semaglutide, the same medicine found in the Wegovy injection, put into a once-daily tablet (FDA). You take one tablet each morning on an empty stomach with up to 4 ounces of plain water. Swallow it whole, then wait at least 30 minutes before you eat, drink, or take any other pills.
GLP-1 stands for glucagon-like peptide-1. It is a hormone your gut releases after you eat, and semaglutide copies that signal to quiet your appetite and slow digestion down (Mayo Clinic). The morning routine matters because food and other liquids can keep the tablet from absorbing the way it should.
The dose goes up little by little, and the full maintenance dose is 25 mg once a day. Set a phone alarm, keep the bottle by your toothbrush, and let the water and the short wait become part of your morning. People who build the habit early tend to have an easier time staying with it.
Does the Wegovy Pill Work as Well as the Shot?
In the OASIS 4 trial, people taking the 25 mg tablet lost about 14% of their body weight over 64 weeks, compared with about 2% for people on a placebo (American College of Cardiology). Those results are roughly in line with the 2.4 mg Wegovy injection, and 30% of the pill group lost at least 20% of their weight.
If you were worried the tablet might be a weaker version of the shot, that is reassuring news. Your own results will depend on where you start, your habits, and how long you stay on the medicine, so treat those trial averages as a guide. That said, the biggest risk in using the oral GLP-1 option is not being able to (or forgetting) to adhere to the strict schedule and routine needed for the pill to work. Eating before those 30 minutes are up or not taking your pill at the same time can lower the effectiveness of the treatment, meaning you may not experience similar results.
Competition among the pills is heating up too, and that usually helps patients over time. If you are curious about what is coming next, take a look at our piece on elecoglipron, the oral GLP-1 pill heading to phase 3.
What Does the Wegovy Pill Cost?
Self-pay pricing through NovoCare starts at $149 a month for the 1.5 mg and 4 mg doses and goes up to $299 a month for the 9 mg and 25 mg doses (NovoCare). The $149 price on the 4 mg dose is a limited-time offer that runs through August 31, 2026, after which it becomes $199.
The $149 price is where you begin, and $299 is what you pay once you reach the top dose. The injectable Wegovy pen runs $349 a month self-pay. So if you pay cash and plan to work up to the 25 mg maintenance dose, budget around $299 a month, and know that the pill still costs $50 less than the pen at that stage if you’re not able to use insurance or the Bridge program (more about that next).
There is a second way to reach the $149 price. The federal TrumpRx platform lists the Wegovy Pill from $149 a month for the 1.5 mg and 4 mg doses (TrumpRx). TrumpRx is a self-pay coupon platform, which means you present the coupon at a pharmacy and pay cash, and it cannot be combined with government insurance.
If you are paying cash and want to shop around, you can compare telehealth providers and pricing through our short survey before you decide.
What This Means for You: The $149 headline price is for the starting doses only. Before you sign up anywhere, ask two questions:
- What will I pay at the 25 mg maintenance dose?
- When does any promotional price end?
A budget built on $299 a month will not catch you off guard later.
How Does the Wegovy Pill Compare to Compounded GLP-1 Options?
A compounded GLP-1 product is one pathway that a prescriber and patient may choose together, and self-pay prices for it commonly run a few hundred dollars to over one thousand dollars a month. The Wegovy Pill now competes directly on price at the starting doses, and it comes with FDA approval, while the compounded route depends on your prescriber's judgment and the pharmacy preparing it.
A little background helps here. After the semaglutide shortage ended, large-scale compounding of these medicines lost its legal basis, so today a GLP-1 compound is prepared for one individual patient under a prescriber's direction. Both are still real options. They are different routes with different oversight, and the right one for you depends on your health history, your prescriber, and your budget. Any medications should be discussed with your clinician, who is the only one who can offer you informed advice on this topic.
What If You Have Insurance or Medicare?
People with commercial insurance that covers the medicine may pay as little as $25 a month for Wegovy or the Wegovy Pill (NovoCare). Medicare Part D members have a new path too. The Medicare GLP-1 Bridge runs from July 1, 2026 through December 31, 2027 and gives eligible beneficiaries a $50 monthly copay (CMS).
The Bridge covers both the Wegovy injection and the Wegovy Pills, along with Zepbound and Foundayo. The program is already active as of July 1, 2026. If you or a parent is on Medicare, the next step is a phone call. Contact your Part D plan directly, ask whether you qualify for the Bridge, and ask how to enroll.
If you have insurance through an employer, call the number on your card and ask whether GLP-1s are covered and what your copay would be. Check every coverage door before you reach for your own wallet.
What This Means for You: A $50 Bridge copay or a $25 commercial copay beats every self-pay price in this article. Cash pricing is your backup plan, so spend twenty minutes on the phone with your plan before you spend $149 or $299 of your own money.
What Side Effects Should You Expect?
The most common side effects of the Wegovy Pill are stomach-related: nausea, diarrhea, vomiting, constipation, and belly pain (FDA). Most people find they ease up over time. In the main trial, 6.9% of the people taking the tablets stopped because of side effects, compared with 5.9% of the placebo group.
That one-point gap between the tablet and the placebo tells you most people find the side effects manageable. Queasiness tends to show up early and around dose increases, so smaller meals, eating slowly, and a little patience go a long way in the first few weeks.
Two items on the label deserve a mention. The label carries a boxed warning about a risk of thyroid C-cell tumors. Gallbladder problems are also listed as a possible risk. Your prescriber will go over your history before writing the prescription, and that conversation is the right place to bring up any thyroid or gallbladder concerns.
What This Means for You: If nausea or other stomach trouble will not settle down, call your prescriber. A slower dose schedule often settles the stomach when willpower alone will not.
Final Takeaway
Three million prescriptions in five months tells you people were waiting for this. Most of them were brand new to GLP-1 therapy. The pill gives them a starting line without a needle. Be sure to look at the whole dosing journey before you commit and ensure you have enough budget to pay the maximum out of pocket before you commit to starting on a GLP-1. Check your insurance and Medicare options first, then compare cash prices. Pick the path you can stay on for the long haul, because staying on the medicine is what brings the results.
If you enjoy posts like these, you can subscribe to receive newsletter updates.
Sources
Keep Reading
Wegovy HD (7.2 mg) is now FDA-approved with 20.7% average weight loss. Learn about results, effects, availability, and how it compares to Zepbound.
Research shows weight regain after stopping Ozempic or Wegovy. See how fast it happens, what else reverses, and what you can do now to keep results.
Compare tirzepatide and semaglutide for weight loss and diabetes including FDA use, side effects, cost, accessibility, and who is likely approved.
Categories
Curated by
